<clinical_study>
  <!-- This xml conforms to an XML Schema at:
    https://clinicaltrials.gov/ct2/html/images/info/public.xsd -->
  <required_header>
    <download_date>ClinicalTrials.gov processed this data on November 19, 2021</download_date>
    <link_text>Link to the current ClinicalTrials.gov record.</link_text>
    <url>https://clinicaltrials.gov/show/NCT02371382</url>
  </required_header>
  <id_info>
    <org_study_id>ORTHO.CR.H41</org_study_id>
    <nct_id>NCT02371382</nct_id>
  </id_info>
  <brief_title>Multicentre Prospective Study to Evaluate Long-term Clinical Outcomes of the Sirius Cemented Femoral Stem</brief_title>
  <acronym>Sirius</acronym>
  <official_title>Multicentre Prospective Study to Evaluate Long-term Clinical Outcomes of the Sirius Cemented Femoral Stem</official_title>
  <sponsors>
    <lead_sponsor>
      <agency>Zimmer Biomet</agency>
      <agency_class>Industry</agency_class>
    </lead_sponsor>
  </sponsors>
  <source>Zimmer Biomet</source>
  <oversight_info>
    <has_dmc>No</has_dmc>
  </oversight_info>
  <brief_summary>
    <textblock>
      The purpose of this multicentre, prospective study is:&#xD;
&#xD;
        -  Document the Clinical and Radiographic performance of the stem at 3 months, 1 year, 3&#xD;
           years, 5 years, 7 and 10 years.&#xD;
&#xD;
        -  Report Safety and Survivorship up to 10 years F/up.&#xD;
    </textblock>
  </brief_summary>
  <detailed_description>
    <textblock>
      This study intends to evaluate the safety and performance of the Sirus cemented hip stem in&#xD;
      terms of function improvement postoperatively, stability and fixation of femoral stem and&#xD;
      survivorship.&#xD;
    </textblock>
  </detailed_description>
  <overall_status>Active, not recruiting</overall_status>
  <start_date>March 2013</start_date>
  <completion_date type="Anticipated">March 2025</completion_date>
  <primary_completion_date type="Anticipated">March 2025</primary_completion_date>
  <study_type>Observational</study_type>
  <has_expanded_access>No</has_expanded_access>
  <study_design_info>
    <observational_model>Cohort</observational_model>
    <time_perspective>Prospective</time_perspective>
  </study_design_info>
  <primary_outcome>
    <measure>Harris Hip Score</measure>
    <time_frame>1 year</time_frame>
    <description>Change in Harris Hip Score from Baseline to 1 Year post-surgery, Harris Hip Score, 0-100 points. The higher the positive difference between baseline and follow up the better the result</description>
  </primary_outcome>
  <secondary_outcome>
    <measure>Oxford Hip score</measure>
    <time_frame>10 years</time_frame>
    <description>Oxford Hip Score at 1,3,5, 7 and 10 year postop, Oxford Hip score 0-48 points, The higher the positive difference the better the result.</description>
  </secondary_outcome>
  <enrollment type="Anticipated">250</enrollment>
  <condition>Arthroplasty, Replacement, Hip</condition>
  <intervention>
    <intervention_type>Device</intervention_type>
    <intervention_name>Arthroplasty hip</intervention_name>
    <description>Hip replacement</description>
  </intervention>
  <eligibility>
    <study_pop>
      <textblock>
        minimum age: 18 maximum age: gender: both&#xD;
      </textblock>
    </study_pop>
    <sampling_method>Probability Sample</sampling_method>
    <criteria>
      <textblock>
        Inclusion Criteria:&#xD;
&#xD;
        Selection of subjects for this evaluation should be in accordance with the indications of&#xD;
        Sirus stem:&#xD;
&#xD;
          1. Non-inflammatory degenerative joint disease including osteoarthritis and avascular&#xD;
             necrosis.&#xD;
&#xD;
          2. Rheumatoid arthritis&#xD;
&#xD;
          3. Correction of functional deformity&#xD;
&#xD;
          4. Treatment of non-union, femoral neck fracture and trochanteric fractures of the&#xD;
             proximal femur with head involvement, unmanageable using other techniques.&#xD;
&#xD;
          5. Revision procedures where other treatments or devices have failed. The Sirius Femoral&#xD;
             Hip Stem is intended for cemented use only and may be used in partial and total hip&#xD;
             arthroplasties&#xD;
&#xD;
        Exclusion Criteria:&#xD;
&#xD;
          -  Absolute contraindications include:&#xD;
&#xD;
        infection, sepsis, osteomyelitis&#xD;
&#xD;
        Additional contraindications include:&#xD;
&#xD;
          -  Uncooperative patient or patient with neurologic disorders who are incapable of&#xD;
             following directions,&#xD;
&#xD;
          -  Osteoporosis,&#xD;
&#xD;
          -  Metabolic disorders which may impair bone formation&#xD;
&#xD;
          -  Osteomalacia&#xD;
&#xD;
          -  Distant foci of infections which may spread to the implant site&#xD;
&#xD;
          -  Rapid joint destruction, marked bone loss or bone resorption apparent on roentgenogram&#xD;
&#xD;
          -  Vascular insufficiency, muscular atrophy or neuromuscular disease.&#xD;
      </textblock>
    </criteria>
    <gender>All</gender>
    <minimum_age>18 Years</minimum_age>
    <maximum_age>N/A</maximum_age>
    <healthy_volunteers>No</healthy_volunteers>
  </eligibility>
  <overall_official>
    <last_name>Alun John</last_name>
    <role>Principal Investigator</role>
    <affiliation>University Hospital of Wales</affiliation>
  </overall_official>
  <overall_official>
    <last_name>Per Kj√¶rsgaard-Andersen, MD</last_name>
    <role>Principal Investigator</role>
    <affiliation>Lillebaelt Hospital Vejle, Denmark</affiliation>
  </overall_official>
  <location>
    <facility>
      <name>Sygehus Vejle</name>
      <address>
        <city>Vejle</city>
        <zip>7100</zip>
        <country>Denmark</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>University Hospital of Wales, Llandough Hospital</name>
      <address>
        <city>Penarth</city>
        <state>Wales</state>
        <zip>CF64 2XX</zip>
        <country>United Kingdom</country>
      </address>
    </facility>
  </location>
  <location_countries>
    <country>Denmark</country>
    <country>United Kingdom</country>
  </location_countries>
  <verification_date>February 2021</verification_date>
  <study_first_submitted>February 19, 2015</study_first_submitted>
  <study_first_submitted_qc>February 19, 2015</study_first_submitted_qc>
  <study_first_posted type="Estimate">February 25, 2015</study_first_posted>
  <last_update_submitted>February 24, 2021</last_update_submitted>
  <last_update_submitted_qc>February 24, 2021</last_update_submitted_qc>
  <last_update_posted type="Actual">February 25, 2021</last_update_posted>
  <responsible_party>
    <responsible_party_type>Sponsor</responsible_party_type>
  </responsible_party>
  <patient_data>
    <sharing_ipd>No</sharing_ipd>
  </patient_data>
  <!-- Results have not yet been posted for this study                                          -->
</clinical_study>

